Aureka Biotechnologies
Builds biological foundation models and closed-loop infrastructure for drug discovery
$100MSeries B
Role not disclosedNC
NRL Capital
Activity from announced rounds
Activity in this selectionallina-health-258a8846
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $200M 2 disclosed · full round size, not this investor’s share